Salivary Gland Surgery — Cost, Top Hospitals & Success Rates | MyMedicPlus

Salivary gland surgery encompasses surgical procedures on the major salivary glands (parotid, submandibular, sublingual) and minor salivary glands (distributed throughout the oral cavity, oropharynx, and paranasal sinuses). The three major paired salivary glands produce saliva essential for taste, mastication, swallowing, speech, and oral mucosal protection (antimicrobial proteins — IgA, lysozyme, mucins). Parotidectomy — surgical removal of part or all of the parotid gland — is the most common major salivary gland procedure and one of the most technically challenging head and neck operations due to the intimate relationship of the facial nerve (CN VII) with the parotid gland. The facial nerve divides within the parotid gland into upper (temporal, zygomatic) and lower (buccal, marginal mandibular, cervical) divisions and must be preserved during parotid surgery — facial nerve monitoring (NIM monitoring) with electromyographic electrodes is mandatory at high-volume centers. The parotid gland is divided into superficial and deep lobes by the facial nerve: superficial parotidectomy (removal of tissue lateral to the nerve) is performed for most benign tumors in the superficial lobe (80-85% of parotid tumors); total parotidectomy (removal of superficial + deep lobe tissue with nerve preservation) for large tumors; deep lobe parotidectomy for parapharyngeal space extension. Sialendoscopy — minimally invasive endoscopic approach to salivary duct systems — treats obstructive salivary gland disease (stones, strictures) without removing the gland, revolutionizing management of sialolithiasis.

Salivary gland surgery is indicated for: parotid gland tumors — 80% of salivary gland tumors; benign: pleomorphic adenoma (most common, 65-70% of parotid tumors — treated by superficial or total parotidectomy with facial nerve preservation; 1-5% recurrence after adequate resection; malignant potential of untreated pleomorphic adenoma — carcinoma ex pleomorphic adenoma); Warthin's tumor (papillary cystadenoma lymphomatosum — 10-15%; older men; bilateral in 10%; superficial parotidectomy curative); malignant parotid tumors — mucoepidermoid carcinoma (most common parotid malignancy — low grade excellent prognosis; high grade poor prognosis; facial nerve sacrifice if involved); adenoid cystic carcinoma (perineural invasion — requires wide margins, may necessitate sacrifice of facial nerve branches; high rate of late distant metastasis); acinic cell carcinoma; carcinoma ex pleomorphic adenoma; submandibular gland — sialolithiasis (stones in Wharton's duct or hilum — most stones 85-90% occur in submandibular gland due to tortuous duct and alkaline thick mucin; endoscopic or surgical stone removal; gland excision if stone in hilum, recurrent, or chronic sclerosing sialadenitis); submandibular gland tumors (same histological types as parotid); sublingual gland — ranula (mucosal retention cyst — plunging ranula extends into the neck; sublingual gland excision ± marsupialization); salivary gland calculi (sialolithiasis) — sialendoscopy (1-2mm mini-endoscope with basket forceps, laser lithotripsy) for accessible stones <7mm; extracorporeal shock wave lithotripsy (ESWL) for some locations; Frey's syndrome (auriculotemporal nerve syndrome — gustatory sweating after parotidectomy — botulinum toxin injection to skin, or Alloderm/SCM interposition during parotidectomy to prevent).

Pre-operative evaluation: history (duration of swelling, pain, meals-related — sialolithiasis causes mealtime swelling and pain; rapid growth — malignancy concern; facial weakness — facial nerve involvement by malignancy; history of cutaneous SCC on face — nodal metastasis to parotid from facial skin cancer); clinical examination (parotid lump: location, size, consistency, facial nerve function assessment — graded House-Brackmann I-VI; bimanual palpation of submandibular duct for stones). Imaging: ultrasound — first-line for all parotid/submandibular masses; characterizes benign (pleomorphic adenoma — well-defined, heterogeneous, hypoechoic) vs malignant (poorly defined, irregular, lymph node involvement) features; FNAC under ultrasound guidance — sensitivity 85-90% for malignancy; MRI parotid — superior soft tissue detail for deep lobe involvement, perineural spread, and skull base extension; CT with contrast — nodal staging for malignant parotid tumors; panoramic OPG — submandibular duct stone localization; Sialo-MRI (magnetic resonance sialography) — duct anatomy, strictures, stones without contrast; facial nerve baseline assessment (electromyography — EMG, ENoG) if pre-operative weakness. Anesthesia and general health: nasal intubation required for parotid surgery to allow mouth to be opened for facial nerve monitoring response assessment; standard cardiac and respiratory fitness for 2-4 hour general anesthesia; anticoagulant management. Preoperative counseling: facial nerve paresis risk, Frey's syndrome risk, great auricular nerve numbness, scar counseling.

Salivary Gland Surgery is performed by oral and maxillofacial surgeons with subspecialty training in facial and jaw surgery, dental implant surgery, and oral oncology. The operative approach is planned using 3D digital workflow: cone-beam CT (CBCT) for bone assessment; 3D model and virtual surgical planning (VSP) for orthognathic and complex reconstruction cases; OPG for dental and jaw anatomy; MRI for soft tissue involvement. Anaesthesia: local anaesthesia with/without sedation for minor procedures (extractions, minor implant surgery, small soft tissue procedures); general anaesthesia via nasotracheal intubation for major jaw surgery, reconstruction, and bilateral procedures — allows unobstructed intraoral surgical access. Fixation hardware: titanium mini-plates and screws (1.5–2.3 mm profile) provide rigid internal fixation for jaw fractures and orthognathic osteotomies; resorbable plates are preferred in children to avoid growth interference; osseointegrated titanium implants (Nobel Biocare, Straumann, Zimmer) achieve bone integration in 12–16 weeks; zirconia implants as metal-free alternative. Surgical access incisions are placed intraorally wherever possible to avoid facial scarring; external incisions (submandibular, preauricular, retromandibular) are used for complex fractures and major reconstructions. Free flap reconstruction (fibula osteocutaneous flap, radial forearm flap, anterolateral thigh flap) is used for major jaw and soft tissue reconstruction after tumour resection. Postoperative care: soft diet 2–6 weeks, oral hygiene with chlorhexidine, prophylactic antibiotics, analgesia.

Parotidectomy outcomes: superficial parotidectomy for pleomorphic adenoma — recurrence rate <2% at 10 years with adequate 'extra-capsular dissection' (ECD) or superficial parotidectomy; enucleation (shelling out without cuff of parotid tissue) historically had 20-45% recurrence — now abandoned; facial nerve outcomes at high-volume centers: temporary weakness 15-25% (recovers fully in 90% by 6-12 months); permanent facial weakness in <3% after superficial parotidectomy; permanent weakness higher for total parotidectomy (5-10%) and malignant tumor surgery where nerve must be dissected from tumor or sacrificed (malignant tumors with preoperative facial palsy — nerve cannot be preserved). Submandibular gland excision outcomes: symptomatic relief in 90-95% of benign disease (sialolithiasis, chronic sialadenitis); marginal mandibular nerve (marginal mandibular branch of facial nerve — courses inferior to submandibular gland) at risk during submandibular dissection — permanent paresis rate 1-3% at high-volume centers; temporary paresis 5-10%. Sialendoscopy outcomes: technically successful stone retrieval in 70-80% of accessible parotid stones; submandibular stone retrieval 60-70%; combined sialendoscopy + external approach for large stones (>7mm) achieves 85-90% gland preservation; gland preservation achieved in 85-90% of patients with sialolithiasis when sialendoscopy is used (vs 100% gland removal with traditional submandibular gland excision); gland function recovery documented by subjective symptom improvement in 80-90% after stone removal. Malignant parotid tumor outcomes: early-stage mucoepidermoid carcinoma (low grade) — 5-year OS >90%; high-grade malignant parotid tumors — 5-year OS 30-50%; adjuvant radiotherapy for high-grade, positive margins, perineural invasion, N+ disease.

Facial nerve injury — the most significant and feared complication of parotid surgery: temporary facial weakness (15-25% after superficial parotidectomy — stretching, traction, and thermal injury to nerve branches during dissection; typically recovers within 3-6 months with physiotherapy; rare permanent weakness <3%); permanent facial palsy after total parotidectomy (5-10%); facial nerve sacrifice required in malignant tumors with preoperative weakness or encased nerve (cable graft reconstruction using sural nerve or greater auricular nerve performed at the time of resection — reinnervation takes 6-18 months, functional recovery in 50-70% of grafts). Frey's syndrome (auriculotemporal nerve syndrome — gustatory sweating): occurs in 30-50% of parotidectomy patients (but symptomatic in only 10-15%); sweating of the cheek overlying the parotid during eating caused by aberrant reinnervation of sweat glands by parasympathetic salivary fibers; treated effectively with botulinum toxin A injection into the skin (starch-iodine test confirms extent) — 90% response, repeat every 6-12 months; prevention by interposing sternocleidomastoid flap or Alloderm between skin and parotid bed. Great auricular nerve sensory loss: numbness around the earlobe and lower ear — unavoidable in most parotid approaches (nerve typically sacrificed to expose the gland); resolves partially in 50-70% at 12-18 months. Hematoma/seroma: 2-5% — managed with drainage. Salivary fistula: persistent saliva drainage through the wound (1-2%); managed with pressure dressing and anticholinergics. Scar: Blair incision (preauricular) heals well with proper closure; hypertrophic scar in <5%.

Post-surgical follow-up for Salivary Gland Surgery is structured to monitor wound healing, infection, and functional recovery. Suture review at 7–10 days post-surgery; wound inspection and oral hygiene reinforcement. Chlorhexidine 0.2% mouthwash 3× daily for the first 2 weeks; soft diet maintained for 2–6 weeks depending on procedure extent. Radiological review (OPG or CBCT) at 6–8 weeks confirms bony healing, implant osseointegration, or fracture union. Physiotherapy with jaw-opening exercises commences at 6 weeks post-surgery to prevent trismus. Orthodontic review (for orthognathic surgery) begins at 6–8 weeks; total orthodontic-surgical treatment time 18–24 months. Implant loading (placing prosthetic crown on implant) occurs at 12 weeks when osseointegration is radiologically confirmed. Oncology patients (oral cancer) require 3-monthly follow-up for 2 years including clinical examination, CT, and dental rehabilitation planning.

Oral and maxillofacial surgery costs for Salivary Gland Surgery vary significantly by procedure complexity and healthcare setting. Minor OMFS (tooth extraction, soft tissue procedures): $50–300 India vs $500–3,000 USA. Surgical wisdom tooth removal: $100–400 India vs $600–3,000 USA per tooth. Dental implant (implant + crown): $600–1,500 India vs $4,000–8,000 USA per implant. Full-arch implant rehabilitation (All-on-4/6): $3,000–8,000 India vs $25,000–60,000 USA — India is among the world's top destinations for dental implant tourism. Orthognathic (jaw) surgery: $5,000–15,000 India vs $40,000–100,000 USA. Facial fracture fixation: $2,000–6,000 India vs $15,000–40,000 USA. Oral cancer surgery with reconstruction (fibula free flap): $8,000–25,000 India vs $80,000–200,000 USA. Thailand, Hungary, and Turkey also offer high-quality maxillofacial surgery at 60–80% lower costs than the USA for international patients.

Non-surgical alternatives to Salivary Gland Surgery are effective for mild-to-moderate conditions. Root canal treatment (endodontic therapy) eliminates dental infection while preserving the tooth — the surgical alternative to extraction for restorable teeth. Conventional dental bridges and removable dentures restore tooth loss without implant surgery — lower immediate cost but different maintenance profile and no bone-preservation benefit. Orthodontic treatment alone corrects mild-to-moderate jaw discrepancies where skeletal correction is not essential — avoids orthognathic surgery for patients with borderline presentation. Physiotherapy and splint therapy resolve 70–80% of TMJ disorders without surgery. CPAP therapy manages obstructive sleep apnea as an alternative to mandibular advancement surgery. Radiation therapy is a non-surgical option for small oral cavity cancers in select anatomical locations. Liquid diet and jaw rest manage facial fractures conservatively in selected non-displaced stable fractures.